Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-12-27 4:43 pm Unchanged |
2023-12-22 | 13D | Theseus Pharmaceuticals, Inc. THRX |
ORBIMED ADVISORS LLC | 17,713,600 40.100% |
0 (Unchanged) |
Filing History |
| 2023-12-15 4:48 pm Sale |
2023-12-13 | 13D | Disc Medicine, Inc. IRON |
ORBIMED ADVISORS LLC | 1,702,237 7.100% |
-567,400 (-25.00%) |
Filing History |
| 2023-12-13 5:20 pm Unchanged |
2023-12-11 | 13D | Keros Therapeutics, Inc. KROS |
ORBIMED ADVISORS LLC | 1,268,734 4.200% |
0 (Unchanged) |
Filing History |
| 2023-12-06 4:43 pm Sale |
2023-12-04 | 13D | SpringWorks Therapeutics, Inc. SWTX |
ORBIMED ADVISORS LLC | 3,567,159 4.900% |
-611,429 (-14.63%) |
Filing History |
| 2023-11-29 4:20 pm Sale |
2023-11-27 | 13D | Apollomics, Inc. APLM |
ORBIMED ADVISORS LLC | 86,155 9.600% |
-9,177 (-9.63%) |
Filing History |
| 2023-11-24 4:28 pm Unchanged |
2023-11-22 | 13D | Theseus Pharmaceuticals, Inc. THRX |
ORBIMED ADVISORS LLC | 17,713,600 40.100% |
0 (Unchanged) |
Filing History |
| 2023-11-20 4:21 pm Sale |
2023-11-16 | 13D | Apollomics, Inc. APLM |
ORBIMED ADVISORS LLC | 95,332 18.100% |
-67,000 (-41.27%) |
Filing History |
| 2023-11-17 08:27 am Unchanged |
2023-11-17 | 13D | Kinnate Biopharma Inc. KNTE |
ORBIMED ADVISORS LLC | 7,559,729 16.000% |
0 (Unchanged) |
Filing History |
| 2023-11-14 4:57 pm Unchanged |
2023-11-13 | 13D | Kinnate Biopharma Inc. KNTE |
ORBIMED ADVISORS LLC | 7,559,729 16.000% |
0 (Unchanged) |
Filing History |
| 2023-11-13 08:51 am Purchase |
2023-11-09 | 13D | Alpine Immune Sciences, Inc. ALPN |
ORBIMED ADVISORS LLC | 4,226,843 7.300% |
145,251 (+3.56%) |
Filing History |
| 2023-11-01 5:08 pm Sale |
2023-10-30 | 13D | Apollomics, Inc. APLM |
ORBIMED ADVISORS LLC | 162,332 18.100% |
-18,105 (-10.03%) |
Filing History |
| 2023-10-04 4:27 pm Purchase |
2023-10-03 | 13D | Synlogic, Inc. SYBX |
ORBIMED ADVISORS LLC | 401,998 4.700% |
401,998 (New Position) |
Filing History |
| 2023-10-02 4:41 pm Purchase |
2023-09-29 | 13D | Apollomics, Inc. APLM |
ORBIMED ADVISORS LLC | 180,436 20.200% |
173,811 (+2623.32%) |
Filing History |
| 2023-09-21 4:52 pm Sale |
2023-08-04 | 13D | Ikena Oncology, Inc. IKNA |
ORBIMED ADVISORS LLC | 2,189,111 5.200% |
-153,121 (-6.54%) |
Filing History |
| 2023-09-18 4:19 pm Sale |
2023-09-12 | 13D | Galecto, Inc. GLTO |
ORBIMED ADVISORS LLC | 29,982 2.800% |
-16,005 (-34.80%) |
Filing History |
| 2023-09-14 4:21 pm Purchase |
2023-08-04 | 13D | Ikena Oncology, Inc. IKNA |
ORBIMED ADVISORS LLC | 2,342,232 5.500% |
405,346 (+20.93%) |
Filing History |
| 2023-09-05 4:20 pm Sale |
2023-08-30 | 13D | Galecto, Inc. GLTO |
ORBIMED ADVISORS LLC | 45,988 4.200% |
-18,315 (-28.48%) |
Filing History |
| 2023-08-23 4:56 pm Sale |
2023-08-09 | 13D | PMV Pharmaceuticals, Inc. PMVP |
ORBIMED ADVISORS LLC | 6,563,077 13.500% |
-26,253 (-0.40%) |
Filing History |
| 2023-08-17 4:30 pm Sale |
2023-08-15 | 13D | Galecto, Inc. GLTO |
ORBIMED ADVISORS LLC | 64,303 5.900% |
-25,354 (-28.28%) |
Filing History |
| 2023-08-11 4:23 pm Purchase |
2023-08-10 | 13D | Gracell Biotechnologies Inc. GRCL |
ORBIMED ADVISORS LLC | 7,641,531 8.000% |
57,955 (+0.76%) |
Filing History |